Literature DB >> 31529264

Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas.

Merwan Ginet1, Timothée Zaragori1,2, Pierre-Yves Marie1,3, Véronique Roch1, Guillaume Gauchotte4,5, Fabien Rech6,7, Marie Blonski6,7, Zohra Lamiral3, Luc Taillandier7,8, Laëtitia Imbert1,2, Antoine Verger9,10.   

Abstract

PURPOSE: 18F-FDopa PET imaging of gliomas is routinely interpreted with standardized uptake value (SUV)-derived indices. This study aimed to determine the added value of dynamic 18F-FDopa PET parameters for predicting the molecular features of newly diagnosed gliomas.
METHODS: We retrospectively included 58 patients having undergone an 18F-FDopa PET for establishing the initial diagnosis of gliomas, whose molecular features were additionally characterized according to the WHO 2016 classification. Dynamic parameters, involving time-to-peak (TTP) values and curve slopes, were tested for the prediction of glioma types in addition to current static parameters, i.e., tumor-to-normal brain or tumor-to-striatum SUV ratios and metabolic tumor volume (MTV).
RESULTS: There were 21 IDH mutant without 1p/19q co-deletion (IDH+/1p19q-) gliomas, 16 IDH mutants with 1p/19q co-deletion (IDH+/1p19q+) gliomas, and 21 IDH wildtype (IDH-) gliomas. Dynamic parameters enabled differentiating the gliomas according to these molecular features, whereas static parameters did not. In particular, a longer TTP was the single best independent predictor for identifying (1) IDH mutation status (area under the curve (AUC) of 0.789, global accuracy of 74% for the criterion of a TTP ≥ 5.4 min) and (2) 1p/19q co-deletion status (AUC of 0.679, global accuracy of 69% for the criterion of a TTP ≥ 6.9 min). Moreover, the TTP from IDH- gliomas was significantly shorter than those from both IDH+/1p19q- and IDH+/1p19q+ (p ≤ 0.007).
CONCLUSION: Prediction of the molecular features of newly diagnosed gliomas with 18F-FDopa PET and especially of the presence or not of an IDH mutation, may be obtained with dynamic but not with current static uptake parameters.

Entities:  

Keywords:  18F-FDopa PET; Diagnosis; Dynamic analysis; Glioma; IDH mutation; WHO 2016 classification

Mesh:

Substances:

Year:  2019        PMID: 31529264     DOI: 10.1007/s00259-019-04509-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  44 in total

Review 1.  Update on amino acid PET of brain tumours.

Authors:  Karl-Josef Langen; Norbert Galldiks
Journal:  Curr Opin Neurol       Date:  2018-08       Impact factor: 5.710

2.  IDH mutation detection in formalin-fixed paraffin-embedded gliomas using multiplex PCR and single-base extension.

Authors:  Marco Perizzolo; Bob Winkfein; Susan Hui; Wally Krulicki; Jennifer A Chan; Douglas J Demetrick
Journal:  Brain Pathol       Date:  2012-04-12       Impact factor: 6.508

Review 3.  Role of amino-acid PET in high-grade gliomas: limitations and perspectives.

Authors:  Antoine Verger; Javier Arbizu; Ian Law
Journal:  Q J Nucl Med Mol Imaging       Date:  2018-04-26       Impact factor: 2.346

4.  IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.

Authors:  A Verger; Ph Metellus; Q Sala; C Colin; E Bialecki; D Taieb; O Chinot; D Figarella-Branger; E Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-14       Impact factor: 9.236

5.  18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

Authors:  Chirag B Patel; Elisa Fazzari; Ararat Chakhoyan; Jingwen Yao; Catalina Raymond; Huytram Nguyen; Jasmine Manoukian; Nhung Nguyen; Whitney Pope; Timothy F Cloughesy; Phioanh L Nghiemphu; Johannes Czernin; Albert Lai; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2018-04-20       Impact factor: 4.130

6.  Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.

Authors:  Antoine Verger; Gabriele Stoffels; Elena K Bauer; Philipp Lohmann; Tobias Blau; Gereon R Fink; Bernd Neumaier; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-17       Impact factor: 9.236

7.  Characteristics of time-activity curves obtained from dynamic 11C-methionine PET in common primary brain tumors.

Authors:  Yuichi Nomura; Yoshitaka Asano; Jun Shinoda; Hirohito Yano; Yuka Ikegame; Tomohiro Kawasaki; Noriyuki Nakayama; Takashi Maruyama; Yoshihiro Muragaki; Toru Iwama
Journal:  J Neurooncol       Date:  2018-03-21       Impact factor: 4.130

8.  Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

Authors:  Barbara J Fueger; Johannes Czernin; Timothy Cloughesy; Daniel H Silverman; Cheri L Geist; Martin A Walter; Christiaan Schiepers; Phioanh Nghiemphu; Albert Lai; Michael E Phelps; Wei Chen
Journal:  J Nucl Med       Date:  2010-09-16       Impact factor: 10.057

9.  Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?

Authors:  Marcus Unterrainer; Florian Schweisthal; Bogdana Suchorska; Vera Wenter; Christine Schmid-Tannwald; Wolfgang P Fendler; Ulrich Schüller; Peter Bartenstein; Jörg-Christian Tonn; Nathalie L Albert
Journal:  J Nucl Med       Date:  2016-03-31       Impact factor: 10.057

10.  [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.

Authors:  Bérengère Dadone-Montaudié; Damien Ambrosetti; Maxime Dufour; Jacques Darcourt; Fabien Almairac; John Coyne; Thierry Virolle; Olivier Humbert; Fanny Burel-Vandenbos
Journal:  PLoS One       Date:  2017-09-22       Impact factor: 3.240

View more
  18 in total

Review 1.  In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography.

Authors:  Cristina Barca; Claudia Foray; Bastian Zinnhardt; Alexandra Winkeler; Ulrich Herrlinger; Oliver M Grauer; Andreas H Jacobs
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

2.  Dynamic 18F-FDOPA-PET/MRI for the preoperative evaluation of gliomas: correlation with stereotactic histopathology.

Authors:  Maria R Ponisio; Jonathan E McConathy; Sonika M Dahiya; Michelle M Miller-Thomas; Keith M Rich; Amber Salter; Qing Wang; Pamela J LaMontagne; Gloria J Guzmán Pérez-Carrillo; Tammie L S Benzinger
Journal:  Neurooncol Pract       Date:  2020-08-07

3.  Heterogeneous parameters based on 18F-FET PET imaging can non-invasively predict tumor grade and isocitrate dehydrogenase gene 1 mutation in untreated gliomas.

Authors:  Tao Hua; Weiyan Zhou; Zhirui Zhou; Yihui Guan; Ming Li
Journal:  Quant Imaging Med Surg       Date:  2021-01

4.  Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas.

Authors:  Hiroyuki Tatekawa; Hiroyuki Uetani; Akifumi Hagiwara; Jingwen Yao; Talia C Oughourlian; Issei Ueda; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Shadfar Bahri; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2021-03-11       Impact factor: 4.130

Review 5.  Use of PET Imaging in Neuro-Oncological Surgery.

Authors:  Adrien Holzgreve; Nathalie L Albert; Norbert Galldiks; Bogdana Suchorska
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

6.  18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study.

Authors:  Timothée Zaragori; Julien Oster; Véronique Roch; Gabriela Hossu; Mohammad B Chawki; Rachel Grignon; Celso Pouget; Guillaume Gauchotte; Fabien Rech; Marie Blonski; Luc Taillandier; Laëtitia Imbert; Antoine Verger
Journal:  J Nucl Med       Date:  2021-05-20       Impact factor: 11.082

7.  Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification.

Authors:  Tomoya Ogawa; Nobuyuki Kawai; Keisuke Miyake; Aya Shinomiya; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  EJNMMI Res       Date:  2020-05-07       Impact factor: 3.138

8.  Effects of Photons Irradiation on 18F-FET and 18F-DOPA Uptake by T98G Glioblastoma Cells.

Authors:  Francesca Pasi; Marco G Persico; Manuela Marenco; Martina Vigorito; Angelica Facoetti; Marina Hodolic; Rosanna Nano; Giorgio Cavenaghi; Lorenzo Lodola; Carlo Aprile
Journal:  Front Neurosci       Date:  2020-11-13       Impact factor: 4.677

9.  Additional Value of 18F-FDOPA Amino Acid Analog Radiotracer to Irradiation Planning Process of Patients With Glioblastoma Multiforme.

Authors:  David Sipos; Zoltan László; Zoltan Tóth; Peter Kovács; Jozsef Tollár; Akos Gulybán; Ferenc Lakosi; Imre Repa; Arpad Kovács
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Additive Value of Dynamic FDOPA PET/CT for Glioma Grading.

Authors:  Antoine Girard; Pierre-Jean Le Reste; Alice Metais; Nibras Chaboub; Anne Devillers; Hervé Saint-Jalmes; Florence Le Jeune; Xavier Palard-Novello
Journal:  Front Med (Lausanne)       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.